Skip to main content
# العنوان سنة البحث
151 NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER. 2015
152 Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer 2015
153 Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma 2015
154 NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER. 2015
155 Navelbine and Capecitabine (Navcap) Followed either by Navcap or by Weekly Docetaxel in the First-Line Treatment of HER-2/neu Negative Metastatic Breast Cancer 2015
156 Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma 2015
157 METRONOMIC CAPECITABINE WITH VINORELBINE AS A SECOND LINE CHEMOTHERAPY IN ADVANCED BREAST CANCER 2015
158 NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER. 2015
159 Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma 2015
160 METRONOMIC CAPECITABINE WITH VINORELBINE AS A SECOND LINE CHEMOTHERAPY IN ADVANCED BREAST CANCER 2015